Flatiron公司的肿瘤学云平台含有一个分析模块,一个电子病历模块,这两者是这家公司近期收购电子病历系统公司Altos Solutions的成果。此外,它还有一个病人入口和计费系统。这些板块和技术加起来就能提供这家公司所称的全球最大的结构化真实肿瘤学数据和信息的单一来源。Flatiron希望,通过让这些数据以符合健康保险便利及责任法案(HIPAA)的方式分享传播,能促进个体化的用药和研究。
The technology is now being used by between 1,500 and 2,000 clinicians and administrators at more than 200 cancer centers, Turner said.
特纳表示,目前有200多家癌症中心的1,500到2,000位临床医生和管理人员已经在使用这一技术。
With $138 million raised so far, the company clearly has clearly captured investors’ attention. Flatiron’s $130 million Series B is the fourth-largest round in which Google Ventures has participated and is its largest medical software deal to date. (The firm also participated in Flatiron’s Series A round.)
这家公司迄今已经募得1.38亿美元,显然早已成为投资者追捧的对象。它的1.3亿美元B轮融资是谷歌风投第四大参投项目,也是其迄今为止规模最大的医药软件投资(谷歌风投也参投了Flatiron的A轮融资。)
Google’s interest in a healthcare company is not that surprising. Last fall, it announced Calico, an effort focused on health and well-being, and its venture arm has investments in Foundation Medicine andDNAnexus. (Google Ventures did not respond to a request for comment.)
【科技是否万能 大数据能够战胜癌症吗】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15